Castle Biosciences Inc
CSTL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001447362
In the last 90 days, Castle Biosciences Inc insiders filed 0 open-market purchases and 21 sales; 176 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Castle Biosciences Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 153 | 2 | 148 | −3 |
| Shares | 22.2M | 335.1K | 22.1M | +254.8K (+1.2%) |
| Value | $522.0M | $7.89M | $501.9M | −$12.1M (−2.4%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Castle Biosciences Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Captrust Financial Advisors | 168,732 | $3.83M | 0.02% |
| SEI Investments Co | 96,327 | $2.19M | 0.00% |
| Invenomic Capital Management LP | 87,252 | $1.98M | 0.11% |
| Orion Portfolio Solutions, LLC | 29,665 | $674.0K | 0.01% |
| ExodusPoint Capital Management, LP | 22,481 | $511.0K | 0.01% |
| XTX Topco Ltd | 16,254 | $369.3K | 0.08% |
| HRT Financial LP | 15,008 | $340.0K | 0.00% |
| Mesirow Financial Investment Management, Inc. | 14,431 | $327.9K | 1.36% |
| Susquehanna International Group, LLP | 11,717 | $266.2K | 0.00% |
| Janus Henderson Group PLC | 9,296 | $211.0K | 0.00% |
| Simplex Trading, LLC | 3,138 | $71.0K | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 199 | $4.52K | 0.00% |
| TCI Wealth Advisors, Inc. | 164 | $3.73K | 0.00% |
| C M Bidwell & Associates Ltd | 75 | $1.70K | 0.00% |
| Baystate Wealth Management LLC | 50 | $1.14K | 0.00% |
Sold out (18)
Institutions that held Castle Biosciences Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Polar Asset Management Partners Inc. | 107,100 | $2.52M |
| Tudor Investment Corp Et Al | 58,903 | $1.39M |
| Premier Fund Managers Ltd | 38,502 | $892.0K |
| Bridgewater Associates, LP | 29,167 | $686.6K |
| D. E. Shaw & Co., Inc. | 28,937 | $681.2K |
| Squarepoint Ops LLC | 13,698 | $322.5K |
| Cambridge Investment Research Advisors, Inc. | 12,501 | $294.0K |
| Versor Investments LP | 11,275 | $265.4K |
| Susquehanna Fundamental Investments, LLC | 8,547 | $201.2K |
| Aquatic Capital Management LLC | 5,400 | $127.0K |
| Rockefeller Capital Management L.P. | 4,294 | $101.0K |
| Lazard Asset Management LLC | 2,183 | $51.0K |
| GWM Advisors LLC | 398 | $9.37K |
| Zions Bancorporation, N.A. | 213 | $5.01K |
| Creative Financial Designs Inc | 200 | $4.71K |
| Truvestments Capital LLC | 135 | $3.18K |
| Accurate Wealth Management, LLC | 61 | $1.51K |
| MBM Wealth Consultants, LLC | 48 | $1.00K |
Not filed for Q1 2023 yet (2)
Institutions that held Castle Biosciences Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Monarch Partners Asset Management LLC | 170,195 | $4.01M |
| Trustcore Financial Services, LLC | 164,897 | $3.88M |